We are international
Donate
TEXT SIZE   
   back

Three Studies Highlighting Myeloma Treatment Advances are Featured Together in the Prestigious New England Journal of Medicine
Studies Cover REVLIMID Continuous Therapy in Newly Diagnosed Myeloma Patients and REVLIMID Maintenance Treatment Following Stem Cell Transplant
05.10.12

Be the first to comment

 related articles